These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27401635)

  • 1. Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer.
    Ban WH; Lee JM; Ha JH; Yeo CD; Kang HH; Rhee CK; Moon HS; Lee SH
    Yonsei Med J; 2016 Sep; 57(5):1063-9. PubMed ID: 27401635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic validation of the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index in inoperable non-small-cell lung cancer.
    Denehy L; Hornsby WE; Herndon JE; Thomas S; Ready NE; Granger CL; Valera L; Kenjale AA; Eves ND; Jones LW
    J Thorac Oncol; 2013 Dec; 8(12):1545-50. PubMed ID: 24389436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
    Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
    Yi YS; Ban WH; Sohng KY
    BMC Cancer; 2018 Oct; 18(1):1053. PubMed ID: 30373585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
    Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary function parameters as prognostic factors in advanced non-small cell lung cancer.
    Rančić M; Ristić L; Rančić S; Radović M; Ćirić Z
    Med Glas (Zenica); 2014 Feb; 11(1):58-65. PubMed ID: 24496342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatment.
    Glattki GP; Manika K; Sichletidis L; Alexe G; Brenke R; Spyratos D
    Am J Clin Oncol; 2012 Apr; 35(2):120-5. PubMed ID: 21378541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current dyspnea among long-term survivors of early-stage non-small cell lung cancer.
    Feinstein MB; Krebs P; Coups EJ; Park BJ; Steingart RM; Burkhalter J; Logue A; Ostroff JS
    J Thorac Oncol; 2010 Aug; 5(8):1221-6. PubMed ID: 20592631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD.
    Kim ES; Kim YT; Kang CH; Park IK; Bae W; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1317-26. PubMed ID: 27366059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of computed tomographic lung volumes in patients with chronic obstructive pulmonary disease.
    Lee JS; Lee SM; Seo JB; Lee SW; Huh JW; Oh YM; Lee SD
    Respiration; 2014; 87(3):196-203. PubMed ID: 24334816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
    Omote N; Hashimoto N; Morise M; Sakamoto K; Miyazaki S; Ando A; Nakahara Y; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3541-3547. PubMed ID: 29270008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study.
    Launois C; Barbe C; Bertin E; Nardi J; Perotin JM; Dury S; Lebargy F; Deslee G
    BMC Pulm Med; 2012 Oct; 12():61. PubMed ID: 23025326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.
    Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL
    BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.
    Iizasa T; Suzuki M; Yasufuku K; Iyoda A; Otsuji M; Yoshida S; Sekine Y; Shibuya K; Saitoh Y; Hiroshima K; Fujisawa T
    Ann Thorac Surg; 2004 Jun; 77(6):1896-902; discussion 1902-3. PubMed ID: 15172232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in pulmonary function and patient-reported outcomes after lung cancer surgery.
    Shin S; Kong S; Kang D; Lee G; Cho JH; Shim YM; Cho J; Kim HK; Park HY
    Respir Res; 2022 Aug; 23(1):224. PubMed ID: 36042472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Chest; 2008 Mar; 133(3):662-9. PubMed ID: 17925418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
    Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
    Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.